AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update – The Baytown Sun

ALAMEDA, Calif.--(BUSINESS WIRE)--Nov 16, 2020--

AgeX Therapeutics, Inc. (AgeX; NYSE American: AGE), a biotechnology company developing innovative regenerative therapeutics to treat human diseases to increase healthspan and combat the effects of aging, reported financial and operating results for the third quarter ended September 30, 2020.

Q3 Highlights

This quarter, we continued to build upon our licensing and collaboration model through our new agreement with ImStem that provides us an avenue for participating financially in potential treatments for COVID-19 and acute respiratory distress syndrome or ARDS. Since the first of the year, AgeX has entered into six agreements that could lead to the development of new cell therapies by our licensees and collaborators, which utilize our core technologies and cell lines with potential future income streams to AgeX, said Greg Bailey M.D., Chairman of AgeX. In addition, expansion of our agreement related to ESI clinical-grade pluripotent stem cell lines will now allow us independence to build ESI cell lines as a to-go-to source for deriving cell based therapeutics across the industry.

Liquidity and Capital Resources

AgeX is in need of additional capital to finance its operations. On March 30, 2020, AgeX entered into a Secured Convertible Facility Agreement (the New Loan Agreement) with Juvenescence Limited pursuant to which AgeX may borrow funds from time to time. As of November 16, 2020, AgeX has borrowed $5.5 million and may draw additional funds from time to time subject to Juvenescences discretion, prior to the contractual repayment date on March 30, 2023. AgeX may not draw down more than $1.0 million in any single draw. More information about the New Loan Agreement can be found in AgeXs Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for the periods ended March 31, 2020, June 30, 2020, and September 30, 2020 filed with the Securities and Exchange Commission on March 30, 2020, May 14, 2020, August 14, 2020, and November 16, 2020, respectively.

Going Concern Considerations

As required under Accounting Standards Update 2014-15, Presentation of Financial Statements-Going Concern (ASC 205-40), AgeX evaluates whether conditions and/or events raise substantial doubt about its ability to meet its future financial obligations as they become due within one year after the date its financial statements are issued. Based on AgeXs most recent projected cash flows, and considering that loans from Juvenescence under the New Loan Agreement will be subject to Juvenescences discretion, AgeX believes that its cash and cash equivalents, the remaining $2.5 million available under the New Loan Agreement and reduction in staff in May 2020 would not be sufficient to satisfy its anticipated operating and other funding requirements for the twelve months following the filing of AgeXs Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2020. These factors raise substantial doubt regarding the ability of AgeX to continue as a going concern.

Third Quarter 2020 Operating Results

Revenues: Total revenues for the third quarter of 2020 were $434,000 as compared with $411,000 for the third quarter of 2019. AgeX revenues are primarily generated from subscription and advertising revenues from the GeneCards online database through its subsidiary LifeMap Sciences, Inc. Revenues in 2020 also included approximately $40,000 of allowable expenses under AgeXs research grant from the NIH. Revenues from that grant were $41,000 in the same period in 2019.

Operating expenses: Operating expenses for the three months ended September 30, 2020 were $2.8 million as compared to $3.6 million for the same period in 2019. Operating expenses are comprised of research and development expense and general and administrative expenses. On an as-adjusted basis, operating expenses for the three months ended September 30, 2020 were $2.3 million as compared to $3.0 million for the same period in 2019.

The reconciliation between GAAP and non-GAAP operating expenses is provided in the financial tables included with this earnings release.

Research and development expenses were $0.8 million during the three months ended September 30, 2020, a $0.6 million decrease from $1.4 million during the same period in 2019. The decrease was primarily attributable to the layoff of 11 research and development personnel in May 2020 and the elimination of shared services payments to Lineage Cell Therapeutics, Inc. (Lineage) with the termination of our Shared Facilities and Services Agreement on September 30, 2019.

General and administrative expenses decreased by $0.3 million to $1.9 million during the three months ended September 30, 2020 from $2.2 million during the same period in 2019 despite an increase in head count resulting from the employment of AgeXs own finance team commencing in October 1, 2019. These increases were offset by a decrease in noncash stock-based compensation expense, travel and related expenses with the shelter in place mandates since March 15, 2020 resulting from the COVID-19 pandemic, and the elimination of shared facilities and services fees from Lineage following the termination of the Shared Facilities and Services Agreement on September 30, 2019.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics to treat human diseases to increase healthspan and combat the effects of aging. AgeXs PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. HyStem is AgeXs delivery technology to stably engraft PureStem or other cell therapies in the body. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

Forward-Looking Statements

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov ). Subsequent events and developments may cause these forward-looking statements to change. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

AGEX THERAPEUTICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT PAR VALUE AMOUNTS)

September 30, 2020

December 31, 2019

(Unaudited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

$

1,107

$

2,352

Accounts and grants receivable, net

241

363

Prepaid expenses and other current assets

581

1,339

Total current assets

1,929

4,054

Property and equipment, net

Excerpt from:
AgeX Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update - The Baytown Sun

Mesenchymal stem cells in the treatment of COVID-19-progress and challenges – DocWire News

This article was originally published here

Sheng Wu Gong Cheng Xue Bao. 2020 Oct 25;36(10):1970-1978. doi: 10.13345/j.cjb.200216.

ABSTRACT

At present, SARS-CoV-2 is raging, and novel coronavirus pneumonia (COVID-19) has caused more than 35 million confirmed patients and more than 500 000 cases death, which seriously endanger human health, socioeconomic development, as well as global medical and public health systems. COVID-19 is highly contagious, has a long incubation period, and causes many death cases due to lack of effective specific treatment. Mesenchymal stem cells have powerful anti-inflammatory and immunoregulatory functions, and can effectively reduce the cytokine storm caused by coronavirus in patients, and improve the pulmonary fibrosis of patients, promote the repair of damaged lung tissue, and reduce the mortality. Currently, a number of related clinical trials of mesenchymal stem cell treatment of COVID-19 have been conducted, and have confirmed the safety and efficacy, suggesting a good clinical application prospect. While progress has been made in mesenchymal stem cell therapy for COVID-19, we should also catch sight of the problems and challenges faced by mesenchymal stem cell clinical trials under severe epidemic situation, including clinical trials design, stem cell quality management, and ethics in treatment. Only by paying attention to these can we guarantee the safe and effective development of mesenchymal stem cell clinical trials in the treatment of COVID-19.

PMID:33169563 | DOI:10.13345/j.cjb.200216

Continue reading here:
Mesenchymal stem cells in the treatment of COVID-19-progress and challenges - DocWire News

The Animal Stem Cell Therapy market to fill the growth bill in the next decade – The Think Curiouser

Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involve three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

Animal Stem Cell Therapy Market: Drivers and Restraints

Increasing prevalence of disease in animals with growing population and to increase the animals quality of life, the companies focus shifting towards animal stem cell therapies. Along with increasing government funding for the protection of animals and fast approvals of FDA contributing towards the rapid growth of the animal stem cell therapy. The research in animal stem cells offers great promise for understanding underlying mechanisms of animal development; it gives great opportunities to treat a broad range of diseases and conditions in animals. Animal stem cell therapy is increasingly recognized as critical translational models of human disease for treatment. All these factors act as drivers for the robust growth of the animal stem cell therapy market.

To remain ahead of your competitors, request for a sample[emailprotected]

https://www.persistencemarketresearch.com/samples/14941

Animal Stem Cell Therapy Market: Segmentation

Segmentation based on Applications

Segmentation based on End-user

Animal Stem Cell Therapy Market: Market Overview

Studies in the animal stem cell therapy continue at a breathtaking pace due to increasing demand and treatment cost covered in reimbursements. And animal stem cell therapy is more effective than traditional treatment available in the market which is boosting the companies to increase the spending in the R&D for innovative methods. Because of the novelty and complexity of animal stem cell therapy, FDA encourages individuals, universities and drug companies for further innovations. The future expected with double CAGR during the forecasted period.

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/14941

Animal Stem Cell Therapy Market: Region-wise Overview

Regarding geographies, North America is dominating the global animal stem cell therapy market due to the increased incidence rate and awareness about the therapy. U.S represents the largest market share in the North America due to the increasing demand for the therapy. Europe and Asia-Pacific are showing a significant growth rate during the forecasted period due to the growing adoption of the animal stem cell therapy. The animal stem cell therapy market in underdeveloped countries is slow when compared to the developed countries.

Animal Stem Cell Therapy Market: Key Participants

The key participants in the animal stem cell therapy market are Magellan Stem Cells, ANIMAL CELL THERAPIES, Abbott Animal Hospital, VETSTEM BIOPHARMA, Veterinary Hospital and Clinic Frisco, CO, etc. The companies are entering into the collaboration and partnership to keep up the pace of the innovations.

You Can Request for TOC Here @https://www.persistencemarketresearch.com/toc/14941

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg Persistence Market Research Address 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. +1-646-568-7751 USA-Canada Toll-free +1 800-961-0353 Sales[emailprotected] Websitehttps://www.persistencemarketresearch.com

The rest is here:
The Animal Stem Cell Therapy market to fill the growth bill in the next decade - The Think Curiouser

Malaysia Animal Stem Cell Therapy Market Size 2020 | Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2027 – Eurowire

Malaysia Animal Stem Cell Therapy Market Overview

The Global Malaysia Animal Stem Cell Therapy Market is showing positive signs of growth. With the current COVID-19 pandemic scenario, new business opportunities are sprouting in the market. Organizations must explore new markets to expand their business globally and locally. For getting a deeper understanding of the emerging trends, the Global Malaysia Animal Stem Cell Therapy Market report showcases various factors that drive the economy worldwide. Moreover, the companies will get to know the market landscape for the next decade 2020-2027.

The Global Malaysia Animal Stem Cell Therapy Market report has been uniquely designed to cater to the needs of the businesses of the 21st century. Going digital is the new normal. Moreover, companies can get to understand their strengths and weaknesses after assessing the market. The next decade is going to be ruled by customer-centric services. To align the business operations, the management team can utilize the actionable recommendations offered at the end of the Global Malaysia Animal Stem Cell Therapy Market report. Factors that can lift or reduce the business are termed as the external factors that also govern the functioning of the market or industries as a whole.

Before designing the blueprint, every business group can go through the Global Malaysia Animal Stem Cell Therapy Market report to understand the key business areas. For shaping a new business venture or expanding into a new market, every company must look into the opportunities and threats that are lurking in the current market. To make an efficient business plan, corporations need to understand the market dynamics that will shape the market in the forecast period (2020-2027).

Following key players have been profiled with the help of proven research methodologies:

Malaysia Animal Stem Cell Therapy Market: Competitive Landscape

To get a head start in a new market, every enterprise needs to understand the competitive landscape and the basic rules that have kept the specific market afloat. The global Malaysia Animal Stem Cell Therapy Market report unravels the secret ingredients used by competitors to meet the demands of their target audience. For specifically understanding the need to balance the capital invested with profits, organizations must use specific indicators. These indicators will not only help in pointing towards growth but also act as an alert to the upcoming threats in the near future. A proper business plan and approach can guarantee a smooth path ahead for every organization.

If the firms believe in offering a memorable experience to their prospective customers, the Global Malaysia Animal Stem Cell Therapy Market report is going to be very useful. Facts and figures are churned into this investigative report to share the strengths and weaknesses of the company. With new technologies being introduced every day, many new entrants have started their business in the market. So, to understand their approach towards the market, the Global Malaysia Animal Stem Cell Therapy Market report has a dedicated section. From the financial aspect to legal, the market report covers all the major things required to study the market and put the business plan in action. Not only this, the competitors added in the report can be altered as per the clients needs and expectations. Furthermore, the companies get a basic outline of moves, in the Global Malaysia Animal Stem Cell Therapy Market report, that can push the business to emerald heights, both in terms of sales and customer generation for the estimated time frame (2020-2027).

Malaysia Animal Stem Cell Therapy Market Segmentation:

The Malaysia Animal Stem Cell Therapy Market has been examined into different global market segments such as type, applications, and global geographies. Each and every global market segment has been studied to get informative insights into various global regions.

Malaysia Animal Stem Cell Therapy Market Segment by Type:

Malaysia Animal Stem Cell Therapy Market Segment by Application:

Malaysia Animal Stem Cell Therapy Market Segment by Global Presence:

North America Latin America Middle East Asia-Pacific Africa Europe

The report has been aggregated by using a couple of research methodologies such as primary and secondary research techniques. It helps in collecting informative pieces of professional information for deriving effective insights into the market. This informative report helps in making well informed and strategic decisions throughout the forecast period.

Malaysia Animal Stem Cell Therapy Market: Scope of the Report

To properly get a deeper understanding of the Global Malaysia Animal Stem Cell Therapy Market, this detailed report is the best choice for businesses. To boost the business along with gaining an edge over the competition, every enterprise needs to focus on the pain points of the market (under investigation). Our experienced professionals have collated facts and figures.

This in-depth analysis has revealed many fascinating facts for organizations. For smooth functioning, every business needs to be flexible towards the latest market trends. For this, the framework must be designed to adapt to the trends running at the moment. An end-to-end examination done on the target crowd helped in building the fundamental segment of the investigation, namely the external factors. These have a high tendency to push or pull the industries. Entire industries can either flourish or wipe out due to these uncontrollable factors. Global Malaysia Animal Stem Cell Therapy market report shows the most affordable options for new as well as established business players to gain market share.

With the highly experienced and motivated team at your service, the team also provides the impact of major factors such as Porters five forces. In the Global Malaysia Animal Stem Cell Therapy Market, every business runs on the image that is generated digitally in the current decade. Hence, companies need to understand the legal hurdles also. Moreover, with the in-depth study conducted across the various market verticals, it is crystal clear that stakeholders also play a significant role in running the business. Get all the details in the Global Malaysia Animal Stem Cell Therapy Market report and understand your competitors.

Key questions answered through this analytical market research report include:

What are the latest trends, new patterns and technological advancements in the Malaysia Animal Stem Cell Therapy Market? Which factors are influencing the Malaysia Animal Stem Cell Therapy Market over the forecast period? What are the global challenges, threats and risks in the Malaysia Animal Stem Cell Therapy Market? Which factors are propelling and restraining the Malaysia Animal Stem Cell Therapy Market? What are the demanding global regions of the Malaysia Animal Stem Cell Therapy Market? What will be the global market size over the coming future? What are the different effective business strategies followed by global companies?

If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Website https://www.marketresearchintellect.com/

More here:
Malaysia Animal Stem Cell Therapy Market Size 2020 | Opportunities, Regional Overview, Top Leaders, Revenue and Forecast to 2027 - Eurowire

Addenbrooke’s becomes first regional centre to offer CAR-T cell treatment for cancer patients – Cambridge Network

The decision to offer the therapy puts Cambridge University Hospitals in the premier league of world class cancer centres.

It also supports progress of the new Cambridge Cancer Research Hospital on the Addenbrookes site, which the Government confirmed in October is included in the second wave of the Hospital Infrastructure Programme (HIP2).

To begin with, the pioneering treatment will be offered to patients with aggressive B-cell lymphomas and acute lymphoblastic leukaemia (ALL) who have relapsed or not responded well to chemotherapy or stem cell treatment.

It is also likely to be offered to cancer patients aged over 70 who are considered to be too high risk to have stem cell transplants.

CAR-T cell therapy can have extremely positive results, but because it can cause unpleasant side effects, it tends to be used when there are few other treatment options available.

CAR-T cell therapy works by re-engineering the patients own immune cells.

Our immune cells, which are called T-cells, circulate around the bloodstream seeking out and destroying any alien intruders, such as infections.

But because cancer cells evolve from our own cells, sometimes our T-cells do not identify them as intruders, and leave them alone.

The new CAR-T cell therapy works by harvesting a patients own T-cells. These are sent to a specialist lab, where they are reprogrammed to express a molecule on their surface, called a Chimeric Antigen Receptor, or CAR, that targets them to the cancer. The reprogrammed cells are grown in a huge numbers over a few weeks and then infused back into the patients body, where they seek out and destroy the cancer. Its a bit like giving immune cells a sat nav.

Until now patients in the east of England needing CAR-T cell therapy have had to make frequent trips to London in preparation for the treatment, which can take another month to administer.

One such patient was Steve Johnson from Bourne who underwent CAR-T cell therapy for relapsed leukaemia at the University College Hospital in London as part of a clinical trial.

Steve explained: "Having the treatment is not pleasant I had a number of fevers and temperature spikes for two weeks after the CAR-T cells were put back in, but I have absolutely no doubt this treatment saved my life and without it I would not be here today."

Steve added: I was lucky for me the trial came at the right time. Having the option to explore and provide revolutionary treatments at places like Addenbrookes and the soon to be built Cambridge Cancer Research Hospital, is vital if we are going to rewrite the story of this devastating illness.

The first patients to be approved for CAR-T cell treatment at Addenbrookes will start having their cells harvested from this week.

Ben Uttenthal, consultant haematologist specialising in CAR-T cell therapy at Addenbrookes, said: This is an exciting new way of treating patients that attacks cancer in a different way from previously available medicines.

"Being able to offer CAR-T cell therapy in our armoury against cancer puts us in the premier league of cancer centres.

It is also a testament to the expertise available across many different specialties in Addenbrookes. Through offering treatments like this, now and in the new Cambridge Cancer Research Hospital, we will be able to benefit cancer patients locally, regionally and nationally.

Initially, the hospital expects to be able to offer CAR-T cell therapy to around 40 patients a year. In the future, treatment is likely to be expanded to include patients with other cancers.

The rest is here:
Addenbrooke's becomes first regional centre to offer CAR-T cell treatment for cancer patients - Cambridge Network

Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 – The Daily Philadelphian

A new Business Intelligence report on the global Stem Cell Therapy Market has recently been added to the Dynamic Report Repository and has been published to provide an exclusive hands-on reference to the various market dynamics that will enable high potential growth in the global Stem Cell Therapy Market. The report presents a market summary, sophisticated TOC, a variety of unique research methodologies, and a research database composed of multiple data sources. This report has been prepared to encourage and guide investor investment with details of the five forces analysis of SWOT, PESTEL and PORTER. This report has been designed with current and past developments in mind that are critical to utilizing profitable predictive developments to ensure steady market growth and uninterrupted survival despite fierce competition in the global Stem Cell Therapy Market.

Sample PDF Brochure with Covid-19 Updates @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=re

A closer look at all growth catalysts and a systematic understanding of the key deterrents that stunt growth. In addition to a global perspective, this report contains identifiable information on growth estimates defined in volume and value-based indices. By carefully measuring the competitive landscape of the global Stem Cell Therapy Market, it categorizes the key players in the sector and encourages novice market participants to set their footholds in the rapid market competition.

This report on the global Stem Cell Therapy Market provides an easily accessible roadmap to assess the league of factors and influencers such as untapped market opportunities and trends pioneering a growth timeline favorable for this market. The thorough and precise market research explanation of this market has awarded a variety of market growth diplomacy and techniques utilized by industry veterans to generate maximum profits in the Stem Cell Therapy Market even in a pandemic such as COVID-19.

The report on the global Stem Cell Therapy Market sets up a detailed overview with relevant references to the market dynamics. Extensive references to the market segment organized by market type and application have been extensively discussed in the report. The volume and value-based growth estimates of the market have been detailed in the report.

Access full research report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=re

Five-Pointer Guide for Report Investment

1. A rigorous, end-to-end review and analysis of the Stem Cell Therapy Market events and their implications 2. A thorough compilation of broad market segments 3. A complete demonstration of best in-industry practices, mindful business decisions and manufacturer activities that steer revenue sustainability in the global Stem Cell Therapy Market 4. A complete assessment of competition spectrum, inclusive of relevant details about key and emerging players 5. A pin-point review of the major dynamics and dominant alterations that influence growth in the global Stem Cell Therapy Market.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

Reasons to Purchase the report:

1. This report provides insights into the global Stem Cell Therapy Market along with the latest market trends and future forecasts to illustrate the future investment pockets. 2. The potential of the global Stem Cell Therapy Market is determined by understanding the effective trends to increase the companys position in the market. 3. This market report provides insights and detailed impact analysis on key influencers, constraints and opportunities. 4. Five Porter strengths analysis to demonstrate the strengths of suppliers and buyers. 5. The latest developments, market shares and strategies used by key market players

Make An Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=re

About Us :

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Original post:
Stem Cell Therapy Market 2020 Industry Size, Trends, Global Growth, Insights And Forecast Research Report 2025 - The Daily Philadelphian

Mesenchymal stem cells in therapy of coronavirus disease 2019 – a review – DocWire News

This article was originally published here

Sheng Wu Gong Cheng Xue Bao. 2020 Oct 25;36(10):1979-1991. doi: 10.13345/j.cjb.200355.

ABSTRACT

Coronavirus disease 2019 (COVID-19) has spread widely on a large scale in the whole world at present, seriously endangering human health. There are still no effective and specific drugs, so it is urgent to find safe and effective therapeutic methods. Mesenchymal stem cells (MSCs) have many biological functions of powerful immunomodulation and tissue repair and regeneration. As a stem cell therapy, it has the potential to reduce the tissue injury and mortality in severe patients infected with novel coronavirus. At present, many research institutions in China and abroad have started a number of clinical research projects about MSCs in the treatment of COVID-19. In addition, those projects have initially confirmed the safety and effectiveness of this therapy. Therefore, this research field has been proved to have a very good clinical therapy prospect.

PMID:33169564 | DOI:10.13345/j.cjb.200355

See the article here:
Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review - DocWire News

Global cryotherapy market size to reach USD 6.72 billion by 2026 – GlobeNewswire

November 16, 2020 05:04 ET | Source: Market Study Report, LLC.

Selbyville, Delaware, Nov. 16, 2020 (GLOBE NEWSWIRE) -- According to industry experts, worldwide cryotherapy market is projected to register a y-o-y growth rate of 9.8% during 2020-2026, subsequently accumulating USD 6.72 billion by the end of the forecast period. Increasing burden of cancer globally, growing preference towards minimally invasive procedures, technological advancements, along with expansion of fitness, wellness, and beauty industries are catalyzing the industry growth.

Proceeding further, the research literature offers an expansive view of the overall industry through a country-level analysis of the regional markets. Moreover, in-depth segmentation studies including device type, therapy type, and application scope are provided to identify the top areas for investments that may yield strong returns in the coming years. Besides, it profiles the top players in this field and uncovers the strategies adopted by them to fortify their position at a global level.

For the uninitiated, cryotherapy is a low temperature application for treating malignant tissues or tissue damage called lesions. This therapy is commonly used in treating sprains, muscle pain, swelling, postoperative swelling, and soft tissue damage. It is also considered to have a high efficacy in cancer treatment. Growing demand of the procedure for aforementioned applications is strengthening global cryotherapy industry outlook.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2963767/

Procedural effectiveness in treating arthritis, rheumatoid conditions, and cardiovascular ailments, in consort with constant advancements are impelling the market expansion.

On the contrary, lack of clinical evidences regarding the use of argon gas and crypto probes as a definitive standard negatively impacts the cryotherapy business landscape. Moreover, high risk linked with cryogenic gases, and strict regulatory policies will restrain global cryotherapy market expansion. However, benefits like higher success rate over traditional surgery, minor scars, less pain, and reduced hospitalization time will bolster the industry growth in the coming years.

Device type overview:

Global cryotherapy market, based on type, is fragmented into cryogun, gas cylinders, cryoprobes, cryochambers, thermocouple devices, and gas pressure gauges. Cryoprobes and cryoguns segments are likely to showcase strong growth over the forecast period as the proper application of cryogenic gases like carbon dioxide, liquid nitrogen, argon, and dimethyl ether-propane require the utilization of these devices in pain management therapies.

Therapy type outline:

Global cryotherapy industry is categorized into cryosurgery, cryo chamber therapy, and icepack therapy, among which, the foremost segment currently holds majority of the industry share. Paradigm shift towards minimally invasive procedure is fostering the demand for cryosurgery. Further, lower side-effects and faster recovery time are likely to boost segmental share in the coming years.

Application scope:

Global cryotherapy market end-user scope is split into cardiology, oncology, dermatology, ophthalmology, pain management, and gynecology. According to trusted records, oncology segment captured majority industry share in recent past and will continue to showcase strong growth trends over 2020-2026, attributable to escalating number of cancer patients and associated deaths across the globe.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/cryotherapy-market-size-share-trends-industry-analysis-report-by-device-type-cryoguns-cryoprobes-gas-cylinders-cryochambers-gas-pressure-gauges-thermocouple-devices-by-therapy-type-cryosurgery-icepack-therapy-chamber-therapy-by-application-type-and-by-regions-segment-forecast-2020-2026

Regional outlook:

At present, North America is the leading contributor to global cryotherapy market remuneration, owing to presence of a well-established healthcare infrastructure, high per capita expenditure, and huge government investment in healthcare. In fact, national healthcare expenditure of the United States was USD 3 trillion in 2014.

Meanwhile, Asia Pacific cryotherapy market is slated to grow exponentially over the projected timeline. Rising awareness regarding cryotherapy, improving healthcare infrastructure, low treatment cost, and rising accessibility to treatment are contributing to the regional industry expansion.

Global Cryotherapy Market Device Type Sub-Segments (Revenue, USD Million, 2015-2026)

Global Cryotherapy Market Therapy Type Sub-Segments (Revenue, USD Million, 2015-2026)

Global Cryotherapy Market Application Sub-Segments (Revenue, USD Million, 2015-2026)

Global Cryotherapy Market Regional Bifurcation (Revenue, USD Million, 2015-2026)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Global Cryotherapy Market Competitive Dashboard (Revenue, USD Million, 2015-2026)

Table of Contents

1. Overview and Scope

1.1. Research goal & scope

1.2. Research assumptions

1.3. Research Methodology

1.3.1. Primary data sources

1.3.2. Secondary data sources

1.4. Key take-aways

1.5. Stakeholders

2. Executive Summary

2.1. Market Definition

2.2. Market Segmentation

3. Industry Insights

3.1. Cryotherapy Market - Industry snapshot

3.2. Cryotherapy Market - Ecosystem analysis

3.3. Cryotherapy Market - Market dynamics

3.3.1. Cryotherapy Market - Market Forces

3.4. Industry analysis - Porter's five force

3.5. Cryotherapy Market PEST analysis, 2019

3.6. Value Chain Analysis

3.7. Cryotherapy Market Industry trends

4. Cryotherapy Market Size and Forecast by Device Type

4.1. Key findings

4.2. Cryoguns

4.2.1. Global market estimates and forecasts, 2015 - 2026

4.3. Cryo Probes

4.3.1. Global market estimates and forecasts, 2015 - 2026

4.4. Gas Cylinders

4.4.1. Global market estimates and forecasts, 2015 - 2026

4.5. Cryo Chambers

4.5.1. Global market estimates and forecasts, 2015 - 2026

4.6. Gas Pressure Gauges

4.6.1. Global market estimates and forecasts, 2015 - 2026

4.7. Thermocouple Devices

4.7.1. Global market estimates and forecasts, 2015 - 2026

5. Cryotherapy Market Size and Forecast by therapy type

5.1. Key Findings

5.2. Cryosurgery

5.2.1. Global market estimates and forecasts, 2015 - 2026

5.3. Icepack Therapy

5.3.1. Global market estimates and forecasts, 2015 - 2026

5.4. Chamber Therapy

5.4.1. Global market estimates and forecasts, 2015 - 2026

6. Cryotherapy Market Size and Forecast by Application Type

6.1. Key Findings

6.2. Oncology

6.2.1. Global market estimates and forecasts, 2015 - 2026

6.3. Cardiology

6.3.1. Global market estimates and forecasts, 2015 - 2026

6.4. Dermatology

6.4.1. Global market estimates and forecasts, 2015 - 2026

6.5. Pain Management

6.5.1. Global market estimates and forecasts, 2015 - 2026

6.6. Ophthalmology

6.6.1. Global market estimates and forecasts, 2015 - 2026

6.7. Gynecology

6.7.1. Global market estimates and forecasts, 2015 - 2026

7. Cryotherapy Market Size and Forecast by Regions

Related Report:

Stem Cell Therapy Market, Technology Potential, Competitive Market Share & Forecast, 2019 2025 Stem Cell Therapy Market will exceed USD 15 billion by 2025, as per a new research report. Increasing research on developing novel therapies and personalized medicines will foster stem cell therapy market growth. For instance, scientists are extensively researching on methods to regenerate healthy heart cells from placenta that can be used in patients after myocardial infarction. This discovery will help to cure patients suffering from cardiovascular diseases and reduce mortality rates. Researchers are further examining different aspects of stem cell therapy for its applications in neurological disorders. Thus, increasing R&D activities to promote developments in stem cell therapy will positively impact the industry growth.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

More here:
Global cryotherapy market size to reach USD 6.72 billion by 2026 - GlobeNewswire

Stem Cell Therapy Market 2020 Future Growth Factors and Opportunities by 2025 – PRnews Leader

This new study of the global Stem Cell Therapy Market added to the burgeoning repositories focuses primarily on decisive market influencing factors such as emerging opportunities, striking end-user profiles, supplier environment, technological innovation and supply advanced business intelligence. This is a reference material. Chain management, including production details, demand cycles and the entire manufacturing cycle collectively affecting the growth. The global Stem Cell Therapy Market report shows the relevant data on segment performance, growth potential over the next few years, supplier and manufacturer activity, and is appropriately aligned with consumption and production development. In addition to adding sub-segments to encourage optimal reader understanding, this report clearly identifies types, applications, and technology categories as key segments. In addition, this Stem Cell Therapy Market report allows readers to understand the absolute monetization potential of each segment, thus identifying one segment to demand the greatest investors interest in high returns.

Sample PDF Brochure with Covid-19 Updates @ https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=re

A thorough assessment of the segment specifications is also elaborately included in the report, clearly highlighting the most dominant segments expected to deviate from revenue maximization in the global Stem Cell Therapy Market through the 2020-25 forecast range. The report also includes details about the assessment presentation by segment. The market has been specifically diversified into dual segments of type and application to maximize the convenience of the reader.

This research representation of the Stem Cell Therapy Market is a thorough combination of important primary and secondary research assumptions. In addition to all this specific developments, the report illuminates the dynamic segmentation of the Stem Cell Therapys market systematically segmented into prominent segments including diversification by type, application, technology, and region. Stem Cell Therapy Market.

The report on the global Stem Cell Therapy Market sets up a detailed overview with relevant references to the market dynamics. Extensive references to the market segment organized by market type and application have been extensively discussed in the report. The volume and value-based growth estimates of the market have been detailed in the report.

Access full research report @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=re

Understanding regional growth development

Pursuing regional assessments and growth potential for each of the mentioned sectors, the report on this global Stem Cell Therapy Market identifies not only specific regional hubs in the five key regions highlighted in the report, but also the remarkable growth advances prevalent across the country.

We closely tracked the monetization trends of each segment highlighted in a specific country to derive actionable insights that effectively steer future-ready investment decisions in the global Stem Cell Therapy Market place.

Stem Cell Therapy Market Segmentation

Type Analysis of Stem Cell Therapy Market:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Applications Analysis of Stem Cell Therapy Market:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

Global Stem Cell Therapy Market 2020-26: Competitive Landscape Analytical Review

Reasons to Purchase the report:

1. This report provides insights into the global Stem Cell Therapy Market along with the latest market trends and future forecasts to illustrate the future investment pockets. 2. The potential of the global Stem Cell Therapy Market is determined by understanding the effective trends to increase the companys position in the market. 3. This market report provides insights and detailed impact analysis on key influencers, constraints and opportunities. 4. Five Porter strengths analysis to demonstrate the strengths of suppliers and buyers. 5. The latest developments, market shares and strategies used by key market players

Make An Enquiry About This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=re

About Us :

Contact Us :

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX75204, U.S.A. Phone No.: USA: +1 972-362 -8199/ +91 9665341414

Continued here:
Stem Cell Therapy Market 2020 Future Growth Factors and Opportunities by 2025 - PRnews Leader

Stem Cell Therapy Market 2020 Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional and Global Industry Forecast To 2025 – PRnews…

Adroit Market Research delivers well-researched industry-wide information on the Stem Cell Therapy market. It provides information on the markets essential aspects such as top participants, factors driving Stem Cell Therapy market growth, precise estimation of the Stem Cell Therapy market size, upcoming trends, changes in consumer behavioral pattern, markets competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the market. Additionally, the report is a compilation of both qualitative and quantitative assessment by industry experts, as well as industry participants across the value chain. The report also focuses on the latest developments that can enhance the performance of various market segments.

This report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Stem Cell Therapy market. The report presents a broad assessment of the market and contains solicitous insights, historical data, and statistically supported and industry-validated market data. The report offers market projections with the help of appropriate assumptions and methodologies. The research report provides information as per the market segments such as geographies, products, technologies, applications, and industries.

A sample of report copy could be downloaded by visiting the site: https://www.adroitmarketresearch.com/contacts/request-sample/691?utm_source=PT

Competitive Landscape: The global Stem Cell Therapy market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graphs, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market. Moreover, it highlights the strategic approaches of the key players towards expanding their product offerings and reinforcing their market presence.

The report analyzes the key elements such as demand, growth rate, cost, capacity utilization, import, margin, and production of the global market players. A number of the factors are considered to analyze the global Stem Cell Therapy Market. The global Stem Cell Therapy Market report demonstrates details of different sections and sub-sections of the global Stem Cell Therapy Market on the basis of topographical regions. The report provides a detailed analysis of the key elements such as developments, trends, projections, drivers, and market growth of the global Stem Cell Therapy Market. It also offers details of the factors directly impacting on the growth of the global Stem Cell Therapy Market. It covers the fundamental ideas related to the growth and the management of the global Stem Cell Therapy Market.

Enquire for in-depth information before buying this report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/691?utm_source=PT

Global Stem Cell Therapy market is segmented based by type, application and region. Based on Type, the market has been segmented into:

Based on cell source, the market has been segmented into,

Adipose Tissue-Derived Mesenchymal SCs Bone Marrow-Derived Mesenchymal SCs Embryonic SCs Other Sources

Based on Application, the market has been segmented into:

Based on therapeutic application, the market has been segmented into,

Musculoskeletal Disorders Wounds & Injuries Cardiovascular Diseases Gastrointestinal Diseases Immune System Diseases Other Applications

Stem Cell Therapy Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Stem Cell Therapy market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Stem Cell Therapy saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans. A special highlight on cost structure, import-export scenario and sales channels of Stem Cell Therapy industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2024 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.

Browse complete Stem Cell Therapy market report description and TOC @ https://www.adroitmarketresearch.com/industry-reports/stem-cell-therapy-market?utm_source=PT

Key Questions Answered in the Report: 1. What is the size of the overall Stem Cell Therapy Market and its segments? 2. What are the key segments and sub-segments in the market? 3. What are the key drivers, restraints, opportunities, and challenges of the Stem Cell Therapy Market and how they are expected to impact the market? 4. What are the attractive investment opportunities within the Market? 5. What is the Stem Cell Therapy Market size at the regional and country-level? 6. Who are the key market players and their key competitors? 7. Market value- chain and key trends impacting every node with reference to companies 8. What are the strategies for growth adopted by the key players in Stem Cell Therapy Market? 9. How does a particular company rank against its competitors with respect to revenue, profit comparison, operational efficiency, cost competitiveness, and market capitalization? 10. How financially strong are the key players in Stem Cell Therapy Market (revenue and profit margin, market capitalization, expenditure analysis, investment analysis)? 11. What are the recent trends in Stem Cell Therapy Market? (M&A, partnerships, new product developments, expansions)

Table of Contents Chapter 1 Stem Cell Therapy Market Overview Chapter 2 Global Economic Impact on Industry Chapter 3 Global Market Competition by Manufacturers Chapter 4 Global Production, Revenue (Value) by Region Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions Chapter 6 Global Production, Revenue (Value), Price Trend by Type Chapter 7 Global Market Analysis by Application Chapter 8 Manufacturing Cost Analysis Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10 Marketing Strategy Analysis, Distributors/Traders Chapter 11 Market Effect Factors Analysis Chapter 12 Global Stem Cell Therapy Market Forecast

Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Ryan Johnson Account Manager Global 3131 McKinney Ave Ste 600, Dallas, TX 75204, U.S.A Phone No.: USA: +1 972-362 -8199 / +91 9665341414

Go here to read the rest:
Stem Cell Therapy Market 2020 Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional and Global Industry Forecast To 2025 - PRnews...